Food and Drug Administration

Drug Safety and Risk Management Adivory Committee

May 18-19, 2005

Briefing Information

Exploration of Issues Related to FDA’s Risk Assessment Program for Marketed Drugs

Disclaimer

Portions of this document have been determined to be exempt from disclosure under the Freedom of Information Act (the FOIA) (5 U.S.C. §552).

These redacted portions will appear as white space on the screen or on the printed page.

FDA Index